位置:首页 > 蛋白库 > PBPA_AQUAE
PBPA_AQUAE
ID   PBPA_AQUAE              Reviewed;         726 AA.
AC   O66874;
DT   20-JUN-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1998, sequence version 1.
DT   03-AUG-2022, entry version 146.
DE   RecName: Full=Penicillin-binding protein 1A;
DE            Short=PBP-1a;
DE            Short=PBP1a;
DE   Includes:
DE     RecName: Full=Penicillin-insensitive transglycosylase;
DE              EC=2.4.1.129 {ECO:0000250|UniProtKB:P02918};
DE     AltName: Full=Peptidoglycan TGase;
DE   Includes:
DE     RecName: Full=Penicillin-sensitive transpeptidase;
DE              EC=3.4.16.4 {ECO:0000250|UniProtKB:P02918};
DE     AltName: Full=DD-transpeptidase;
GN   Name=mrcA; Synonyms=ponA; OrderedLocusNames=aq_624;
OS   Aquifex aeolicus (strain VF5).
OC   Bacteria; Aquificae; Aquificales; Aquificaceae; Aquifex.
OX   NCBI_TaxID=224324;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=VF5;
RX   PubMed=9537320; DOI=10.1038/32831;
RA   Deckert G., Warren P.V., Gaasterland T., Young W.G., Lenox A.L.,
RA   Graham D.E., Overbeek R., Snead M.A., Keller M., Aujay M., Huber R.,
RA   Feldman R.A., Short J.M., Olsen G.J., Swanson R.V.;
RT   "The complete genome of the hyperthermophilic bacterium Aquifex aeolicus.";
RL   Nature 392:353-358(1998).
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=[GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-
CC         Ala)](n)-di-trans,octa-cis-undecaprenyl diphosphate + beta-D-GlcNAc-
CC         (1->4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala)-di-trans,octa-
CC         cis-undecaprenyl diphosphate = [GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-gamma-
CC         D-Glu-L-Lys-D-Ala-D-Ala)](n+1)-di-trans-octa-cis-undecaprenyl
CC         diphosphate + di-trans,octa-cis-undecaprenyl diphosphate + H(+);
CC         Xref=Rhea:RHEA:23708, Rhea:RHEA-COMP:9602, Rhea:RHEA-COMP:9603,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:58405, ChEBI:CHEBI:60033,
CC         ChEBI:CHEBI:78435; EC=2.4.1.129;
CC         Evidence={ECO:0000250|UniProtKB:P02918};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Preferential cleavage: (Ac)2-L-Lys-D-Ala-|-D-Ala. Also
CC         transpeptidation of peptidyl-alanyl moieties that are N-acyl
CC         substituents of D-alanine.; EC=3.4.16.4;
CC         Evidence={ECO:0000250|UniProtKB:P02918};
CC   -!- PATHWAY: Cell wall biogenesis; peptidoglycan biosynthesis.
CC   -!- INTERACTION:
CC       O66874; O66874: mrcA; NbExp=2; IntAct=EBI-15625175, EBI-15625175;
CC   -!- SUBCELLULAR LOCATION: Cell inner membrane {ECO:0000250}; Single-pass
CC       type II membrane protein {ECO:0000250}.
CC   -!- SIMILARITY: In the N-terminal section; belongs to the
CC       glycosyltransferase 51 family. {ECO:0000305}.
CC   -!- SIMILARITY: In the C-terminal section; belongs to the transpeptidase
CC       family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AE000657; AAC06835.1; -; Genomic_DNA.
DR   PIR; F70355; F70355.
DR   RefSeq; NP_213434.1; NC_000918.1.
DR   RefSeq; WP_010880372.1; NC_000918.1.
DR   PDB; 2OQO; X-ray; 2.10 A; A=51-243.
DR   PDB; 3D3H; X-ray; 2.31 A; A=51-243.
DR   PDB; 3NB6; X-ray; 2.70 A; A=51-243.
DR   PDB; 3NB7; X-ray; 2.65 A; A=51-243.
DR   PDBsum; 2OQO; -.
DR   PDBsum; 3D3H; -.
DR   PDBsum; 3NB6; -.
DR   PDBsum; 3NB7; -.
DR   AlphaFoldDB; O66874; -.
DR   SMR; O66874; -.
DR   DIP; DIP-60897N; -.
DR   STRING; 224324.aq_624; -.
DR   CAZy; GT51; Glycosyltransferase Family 51.
DR   EnsemblBacteria; AAC06835; AAC06835; aq_624.
DR   KEGG; aae:aq_624; -.
DR   PATRIC; fig|224324.8.peg.507; -.
DR   eggNOG; COG5009; Bacteria.
DR   HOGENOM; CLU_006354_2_4_0; -.
DR   InParanoid; O66874; -.
DR   OMA; LAQMAMI; -.
DR   OrthoDB; 652304at2; -.
DR   BRENDA; 2.4.1.129; 396.
DR   UniPathway; UPA00219; -.
DR   EvolutionaryTrace; O66874; -.
DR   Proteomes; UP000000798; Chromosome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0008658; F:penicillin binding; IBA:GO_Central.
DR   GO; GO:0008955; F:peptidoglycan glycosyltransferase activity; IBA:GO_Central.
DR   GO; GO:0009002; F:serine-type D-Ala-D-Ala carboxypeptidase activity; IEA:UniProtKB-EC.
DR   GO; GO:0071555; P:cell wall organization; IEA:UniProtKB-KW.
DR   GO; GO:0009252; P:peptidoglycan biosynthetic process; IBA:GO_Central.
DR   GO; GO:0006508; P:proteolysis; IEA:UniProtKB-KW.
DR   GO; GO:0008360; P:regulation of cell shape; IEA:UniProtKB-KW.
DR   GO; GO:0046677; P:response to antibiotic; IBA:GO_Central.
DR   Gene3D; 1.10.3810.10; -; 1.
DR   Gene3D; 3.40.710.10; -; 2.
DR   InterPro; IPR012338; Beta-lactam/transpept-like.
DR   InterPro; IPR001264; Glyco_trans_51.
DR   InterPro; IPR023346; Lysozyme-like_dom_sf.
DR   InterPro; IPR036950; PBP_transglycosylase.
DR   InterPro; IPR001460; PCN-bd_Tpept.
DR   Pfam; PF00912; Transgly; 1.
DR   Pfam; PF00905; Transpeptidase; 1.
DR   SUPFAM; SSF53955; SSF53955; 1.
DR   SUPFAM; SSF56601; SSF56601; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Antibiotic resistance; Carboxypeptidase; Cell inner membrane;
KW   Cell membrane; Cell shape; Cell wall biogenesis/degradation;
KW   Glycosyltransferase; Hydrolase; Membrane; Multifunctional enzyme;
KW   Peptidoglycan synthesis; Protease; Reference proteome; Signal-anchor;
KW   Transferase; Transmembrane; Transmembrane helix.
FT   CHAIN           1..726
FT                   /note="Penicillin-binding protein 1A"
FT                   /id="PRO_0000083178"
FT   TOPO_DOM        1..3
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        4..24
FT                   /note="Helical; Signal-anchor for type II membrane protein"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        25..726
FT                   /note="Periplasmic"
FT                   /evidence="ECO:0000255"
FT   REGION          45..213
FT                   /note="Transglycosylase"
FT   REGION          379..662
FT                   /note="Transpeptidase"
FT   ACT_SITE        83
FT                   /note="Proton donor; for transglycosylase activity"
FT                   /evidence="ECO:0000250|UniProtKB:P02919"
FT   ACT_SITE        432
FT                   /note="Acyl-ester intermediate; for transpeptidase
FT                   activity"
FT                   /evidence="ECO:0000250|UniProtKB:P02919"
FT   HELIX           60..62
FT                   /evidence="ECO:0007829|PDB:2OQO"
FT   HELIX           68..70
FT                   /evidence="ECO:0007829|PDB:2OQO"
FT   HELIX           73..83
FT                   /evidence="ECO:0007829|PDB:2OQO"
FT   TURN            85..89
FT                   /evidence="ECO:0007829|PDB:2OQO"
FT   STRAND          90..93
FT                   /evidence="ECO:0007829|PDB:2OQO"
FT   HELIX           95..102
FT                   /evidence="ECO:0007829|PDB:2OQO"
FT   HELIX           118..124
FT                   /evidence="ECO:0007829|PDB:2OQO"
FT   STRAND          127..129
FT                   /evidence="ECO:0007829|PDB:2OQO"
FT   HELIX           134..150
FT                   /evidence="ECO:0007829|PDB:2OQO"
FT   HELIX           153..163
FT                   /evidence="ECO:0007829|PDB:2OQO"
FT   HELIX           173..181
FT                   /evidence="ECO:0007829|PDB:2OQO"
FT   HELIX           185..187
FT                   /evidence="ECO:0007829|PDB:2OQO"
FT   HELIX           190..198
FT                   /evidence="ECO:0007829|PDB:2OQO"
FT   HELIX           203..206
FT                   /evidence="ECO:0007829|PDB:2OQO"
FT   TURN            208..210
FT                   /evidence="ECO:0007829|PDB:2OQO"
FT   HELIX           212..228
FT                   /evidence="ECO:0007829|PDB:2OQO"
FT   HELIX           234..241
FT                   /evidence="ECO:0007829|PDB:2OQO"
SQ   SEQUENCE   726 AA;  81824 MW;  37F756397C9D7B38 CRC64;
     MKKLVIGILG IVIALFVGLL VFLIPIYKNL PDPKLLESWT PPQASEVYDA KGRLYGTIGI
     QKRFYVSIDK IPEHVINAFV ATEDRNFWHH FGIDPVAIVR AAIVNYRAGR IVQGGSTITQ
     QLAKNLFLTR ERTLERKIKE ALLAIKIERT FDKKKIMELY LNQIYLGSGA YGVEAAAQVY
     FGKHVWELSL DEAALLAALP KAPAKYNPFY HPERALQRRN LVLKRMLEEG YITPEQYEEA
     VNKPLTVKKE NKYKFSDYFL DMVKSYVFNK YGEIAYKGRL KIYTTIDLDY QKIAQKSLEE
     GLKRVAKIIG LPFLPKSEED MELAYEKEAQ LKRLKRGKIY VAKILKYDGN FMKVEIHGKK
     LKGEIKGLNT EGHKYVFVKY LGGNRAEIIP DLEGSLVSID VKTGEIKAIV GGRSYAYSQF
     NRAVKALRQP GSAIKPVIYL SALLKGMTQI STIDASSKPY YDPSKGEDWI PKNYDEKEYG
     NVTLRYALAH SINTAAVNLL DKVGFELVLE VGKKVGLDNL KPYYSLALGT VEVTPLQLTA
     AYQVFANLGT ECKPFFIKKI VDENGEVLEE NVPECEEVLP KPETRVPVDM LRAVVLEGTA
     RRASVLDRIV AGKTGTTDDF QDAWFVGFSP YIVTGVWVGY DVKKSLGKHM SGSRVALPIW
     IDYMKVVTRM YPNEDFELPP ENIVVNINPK DLVLADETCE GVPMVFVKGT EPHITCSDLN
     AILGLR
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2025